Cart
sales@molnova.com
BW-A78U
CAS No. 101155-02-6
BW-A78U( —— )
Catalog No. M19920 CAS No. 101155-02-6
BW-A 78U is a PDE4 inhibitor (IC50: 3 μM). It is not inhibition on the lipopolysaccharide (LPS)-induced TNF-α release.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 35 | In Stock |
|
| 5MG | 98 | In Stock |
|
| 10MG | 147 | In Stock |
|
| 25MG | 249 | In Stock |
|
| 50MG | 351 | In Stock |
|
| 100MG | 496 | In Stock |
|
| 200MG | 681 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBW-A78U
-
NoteResearch use only, not for human use.
-
Brief DescriptionBW-A 78U is a PDE4 inhibitor (IC50: 3 μM). It is not inhibition on the lipopolysaccharide (LPS)-induced TNF-α release.
-
DescriptionBW-A 78U is a PDE4 inhibitor (IC50: 3 μM). It is not inhibition on the lipopolysaccharide (LPS)-induced TNF-α release.
-
In VitroBW-A 78U is a PDE4 inhibitor with an IC50 of 3 μM. BW-A 78U fails to significantly inhibit arachidonate release.BW-A 78U is ineffective to inhibit the lipopolysaccharide (LPS)-induced TNF-α release.
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetPDE
-
RecptorPDE4
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number101155-02-6
-
Formula Weight257.27
-
Molecular FormulaC13H12FN5
-
Purity>98% (HPLC)
-
SolubilityDMSO: 100 mg/mL
-
SMILESCNc1ncnc2n(Cc3ccccc3F)cnc12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Boichot E et al. Anti-inflammatory activities of a new series of selective phosphodiesterase 4 inhibitors derivedfrom 9-benzyladenine. J Pharmacol Exp Ther. 2000 Feb;292(2):647-53.
molnova catalog
related products
-
CI-1044
CI-1044 is a potent, selective and orally bioavailable PDE4 inhibitor with IC50 of 0.27 uM.
-
BI 1015550
Nerandomilast (BI 1015550) is an orally active PDE4B inhibitor with IC50 of 7.2 nM. BI 1015550 has potential applications in inflammation, allergic diseases, pulmonary fibrosis and chronic obstructive pulmonary disease (COPD) with a good safety profile.
-
Enpp-1-IN-14
ENPP1-IN-2 is a potent inhibitor of Ectonucleotide Pyrophosphatase/Phosphodiesterase-1 (ENPP1) with an IC50 value of 32.38 nM for recombinant human ENPP-1. ENPP1-IN-2 has anti-tumor activity.
